Sciensus

United Kingdom Founded: 1992 • Age: 34 yrs Acquired By Healthcare at Home
Home-based treatment, medication, and health care support are provided.

About Sciensus

Sciensus is a Healthcare company based in United Kingdom founded in 1992 by Charles Walsh, and was acquired by Healthcare at Home in January 2011. Home-based treatment, medication, and health care support are provided. Sciensus has completed 1 acquisition, including Vine Health. Its chief executive, as recorded, is Darryn Gibson. Its website sciensus.com draws about 29 thousand monthly visits. Sciensus offers products and services including Sciensus Intouch App, Sciensus Cancer Companion App, and Patient Support Programs. Its focus areas include Home Healthcare. Its legal entity is SCIENSUS PHARMA SERVICES LIMITED. Its competitors include Bluebird Care, Hurdle and CSN Care Group; 1 of its 3 listed competitors has raised funding.

Company details

Sciensus was founded in 1992 in the United Kingdom and operates within the health care sector. Services focused on treatment, medication delivery, and ongoing support are delivered directly to patients homes. Operations emphasize accessibility for chronic conditions and specialized care needs, with a network covering the UK. Leadership includes founder Charles Walsh and CEO Darryn Gibson, guiding the companys expansion in home health solutions.

  • Headquarters United Kingdom
  • Founders Charles Walsh
  • Stage Acquired
  • Sectors
    Healthcare
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website sciensus.com
  • Social LinkedIn X Facebook YouTube
  • Acquired by Healthcare at Home (Jan 2011)
  • Legal Name Sciensus Pharma Services Limited
  • Date of Incorporation 28 Oct, 1992
  • Jurisdiction BURTON-ON-TRENT, STAFFORDSHIRE, ENGLAND
Key Metrics

Products & Services of Sciensus

Sciensus offers a comprehensive portfolio of products and services, including Sciensus Intouch App, Sciensus Cancer Companion App, and Patient Support Programs.

Sciensus Intouch App
Digital Health App

App for patient information access and support services.

Sciensus Cancer Companion App
Cancer Support App

App providing personalized interventions for cancer patients.

Patient Support Programs
Healthcare Services

Programs to enhance patient engagement and treatment adherence.

Apps and channels of Sciensus

its YouTube channel Sciensus has 287 subscribers and 25 videos.

Sciensus
YouTube 287 subscribers 25 videos Science & Technology
Open channel

Videos from Sciensus

The most watched videos on Sciensus's YouTube channel, Sciensus (287 subscribers). Click a video to play it here.

Working at Sciensus - Hear from Lesley, Specialist Chemotherapy nurse
483 views
Sciensus Intouch App - benefits and features
328 views
Bespoke rare disease pharmaceutical services | Sciensus
242 views
Supporting NHS Cancer Services with Sciensus: Interview with NHS Services Director Victoria Deadman
233 views

More on Sciensus.

Funding Insights of Sciensus

  • Total Rounds 3
  • Investors Count 2

All 3 funding rounds of Sciensus with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Feb 2012Private Equity Round––
Feb 2012Private Equity Round–Vitruvian Partners
–
Oct 2007Debt – Conventional––
Valuation history

3 investors in total: 3 institutional.

Investors in Sciensus

Sciensus has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Vitruvian Partners, Ardian and Sciensus.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Growth equity investments are directed toward expanding startups across sectors.
vitruvianpartners.comLondon, United Kingdom
Private investment firm specializing in markets and partnerships.
ardian.com
Sciensus is recognized as a leading life sciences organization focused on patient care.
hah.co.ukUnited Kingdom
Premium access

Investor details for Sciensus

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Sciensus

6 people are tracked at Sciensus (5 in leadership, 1 in team).

NameRoleGroup
Charles Walsh
FounderLeadership
Darryn Gibson
CEOLeadership
Jonathan Asbridge
Chief Clinical OfficerLeadership
Gordon Cox
COOLeadership
Richard Blyth
Chief Customer OfficerLeadership
John Bradshaw
Group Company SecretaryTeam
Premium access

Complete people profiles for Sciensus

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Sciensus

Sciensus has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Vine Health.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Cancer treatment is managed via a social tracking app.
vinehealth.aiLondon, United Kingdom2018Jan 2024β€’β€’β€’β€’
Premium access

Complete acquisition details for Sciensus

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Sciensus

5 dated milestones of Sciensus across 32 years, from founding to its latest funding, stage changes and deals.

  1. Founded Sciensus is founded.
  2. Funding First funding round.
  3. Exit Acquired by Healthcare at Home.
  4. Funding Latest funding round, Private Equity Round,.
  5. Acquisition Acquires Vine Health.

Competitors of Sciensus

Sciensus has 3 listed competitors in our database, 1 of them funded. They include Bluebird Care, Hurdle and CSN Care Group.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
bluebirdcare.co.uk2004Waterlooville, United Kingdom
Provider of home care and support services
hurdle.bio2017London, United Kingdom28
Home diagnostic testing services are offered by Hurdle.
csncare.co.uk2019Milton Keynes, United Kingdom$5.48M
Diversified home health care services are provided across the UK.
Premium access

Detailed competitors of Sciensus

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Sciensus

The website of Sciensus (sciensus.com) receives about 28.8K visits a month.

  • Monthly visits
    28.8K

    ▼ 3% vs previous month

Similar websites

Websites whose visitors overlap most with Sciensus. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
hah.co.uk
100%
View details
healthinformaticsforum.com
healthinformaticsforum.com
78%
–
informatica2009.sld.cu
informatica2009.sld.cu
78%
–
amorphous.com.my
amorphous.com.my
78%
–
clevelandcliniclondon.uk
53%
#272,329View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 9 similar websites and full traffic analytics for Sciensus

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 9 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Sciensus

Premium access

Complete news archive for Sciensus

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sciensus

Sciensus was founded in 1992 and raised its 1st funding round 15 years after it was founded.

Sciensus is headquartered in United Kingdom.

Darryn Gibson is the CEO of Sciensus, as recorded in our data.

Sciensus was founded in 1992 in the United Kingdom and operates within the health care sector. Services focused on treatment, medication delivery, and ongoing support are delivered directly to patients homes. Operations emphasize accessibility for chronic conditions and specialized care needs, with a network covering the UK. Leadership includes founder Charles Walsh and CEO Darryn Gibson, guiding the companys expansion in home health solutions.

Sciensus's top competitors include Hurdle, Bluebird Care and CSN Care Group.

Sciensus offers Sciensus Intouch App, Sciensus Cancer Companion App, and Patient Support Programs.

Sciensus has made 1 acquisition, including Vine Health.

Sciensus has 3 investors. Key investors include Vitruvian Partners, Ardian, and Sciensus.

Sciensus operates through Sciensus Pharma Services Limited.

Yes. Sciensus was acquired by Healthcare at Home in January 2011.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available